Agios Pharmaceuticals AGIO
NASDAQ AGIO
$31.94 -0.53 (-1.65%)
As of: Oct 2, 2026 · 12:36 PM EDT

Agios Pharmaceuticals (AGIO) Net Equity Issued and Repurchased (2012 - 2026)

Updated

Agios Pharmaceuticals (AGIO) reported Net Equity Issued and Repurchased of $3.15 million for Q2 2026, compared with $65,000 a year earlier and up 51.5% from the prior quarter.

Analysis

Agios Pharmaceuticals (AGIO) Net Equity Issued and Repurchased (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Agios Pharmaceuticals' Net Equity Issued and Repurchased came in at $12.22 million, up 33.4% year-over-year; for FY2025, it was $8.68 million, down 39.9% from FY2024.

  • Net Equity Issued and Repurchased has a five-year compound annual growth rate of -5.2% (FY2020 to FY2025).
  • By year, Net Equity Issued and Repurchased came in at $14.44 million in FY2024 (+165.8%), $5.43 million in FY2023 (+102.6%), $2.68 million in FY2022 (-92.8%) and $37.3 million in FY2021 (+229.6%).
  • Five-year quarterly Net Equity Issued and Repurchased spans a low of $16,000 in Q2 2022 and a high of $5.86 million in Q1 2024.
  • Year over year, Net Equity Issued and Repurchased gained in four of the last seven quarters, with growth averaging 56.4%.
  • The high point for year-over-year Net Equity Issued and Repurchased in five years was Q4 2023 (growth of 706.7%); the low point was Q2 2022 (a decline of 99.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.08 million (Q1 2026), $2.56 million (Q4 2025) and $4.44 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Agios Pharmaceuticals 1.98 Bn 1.98 Bn 41.75 Mn 3.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.15 Mn
Mar 31, 2026 2.08 Mn
Dec 31, 2025 2.56 Mn
Sep 30, 2025 4.44 Mn
Jun 30, 2025 65,000.00
Mar 31, 2025 1.62 Mn
Dec 31, 2024 4.84 Mn
Sep 30, 2024 2.64 Mn
Jun 30, 2024 1.10 Mn
Mar 31, 2024 5.86 Mn
Dec 31, 2023 847,000.00
Sep 30, 2023 1.88 Mn
Jun 30, 2023 237,000.00
Mar 31, 2023 2.47 Mn
Dec 31, 2022 105,000.00
Sep 30, 2022 1.27 Mn
Jun 30, 2022 16,000.00
Mar 31, 2022 1.29 Mn
Dec 31, 2021 267,000.00
Sep 30, 2021 4.01 Mn
API Access

Agios Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AGIO&period=max&api_key=YOUR_API_KEY